Register Login
Register to leave comments
  • News bot April 7, 2026, 11:05 a.m.

    📋 GT BIOPHARMA, INC. (GTBP) - Clinical Trial Update

    Filing Date: 2026-04-07

    Accepted: 2026-04-07 07:05:14

    Event Type: Clinical Trial Update

    Event Details:

    GT BIOPHARMA, INC. (GTBP) Announces Clinical Trial Update GT BIOPHARMA, INC. (GTBP) provided an update on its clinical development programs. Clinical Development Highlights:
    • Collaboration: Registrant

    🔬 Clinical Development Pipeline (GT BIOPHARMA, INC.):

    Product Type Development Stage Therapeutic Area Source
    Xeruborbactam Oral Prodrug Placebo DRUG Phase PHASE1 Bacterial Infections ClinicalTrials.gov
    Custom-made guides and plates DEVICE Preclinical Surgery ClinicalTrials.gov
    Amiloride DRUG Phase PHASE2 HER2 Low Breast Carcinoma ClinicalTrials.gov
    Biospecimen Collection PROCEDURE Phase PHASE2 HER2 Low Breast Carcinoma ClinicalTrials.gov
    Computed Tomography (CT) PROCEDURE Phase PHASE2 HER2 Low Breast Carcinoma ClinicalTrials.gov
    Psilocybin DRUG Phase PHASE2 Opioid-Related Disorders ClinicalTrials.gov
    ARX788 DRUG Phase PHASE2 HER2 Positive Metastatic Breast Cancer ClinicalTrials.gov
    BE-101 DRUG Phase PHASE1 Hemophilia B ClinicalTrials.gov
    Placebo for RAP200mg DRUG Phase PHASE2 Psoriasis ClinicalTrials.gov
    Placebo for RAP400 DRUG Phase PHASE2 Psoriasis ClinicalTrials.gov
    RAP103 200mg BID DRUG Phase PHASE2 Psoriasis ClinicalTrials.gov
    RAP103 400mg single dose DRUG Phase PHASE2 Psoriasis ClinicalTrials.gov
    Nicardipine DRUG Phase PHASE4 Hypertension ClinicalTrials.gov
    alfimeprase DRUG Phase PHASE3 Arterial Occlusive Diseases ClinicalTrials.gov
    C2L-OCT-01 PR, 20 mg DRUG Phase PHASE3 Acromegaly ClinicalTrials.gov
    C2L-OCT-01 PR, 10 or 20 mg DRUG Phase PHASE3 Acromegaly ClinicalTrials.gov
    Visilizumab (Nuvion®; HuM291) DRUG Preclinical Ulcerative Colitis ClinicalTrials.gov
    recombinant nematode anticoagulant protein c2 (rNAPc2) DRUG Phase PHASE1 Colon Cancer ClinicalTrials.gov
    PCK3145 DRUG Phase PHASE1 Prostate Cancer ClinicalTrials.gov
    M200 (volociximab) in Combination with Dacarbazine (DTIC) DRUG Phase PHASE2 Melanoma ClinicalTrials.gov
    C2L-OCT-01 PR 30 mg DRUG Phase PHASE3 Acromegaly ClinicalTrials.gov
    Octreotide acetate prolonged release, 30 mg DRUG Phase PHASE3 Acromegaly ClinicalTrials.gov
    C2L-OCT-01 PR, 30 mg DRUG Phase PHASE3 Acromegaly ClinicalTrials.gov
    Daclizumab (Anti-CD25 Humanized Monoclonal Antibody) DRUG Phase PHASE2 Multiple Sclerosis ClinicalTrials.gov
    Visilizumab (HuM291; Nuvion®) DRUG Phase PHASE3 Intravenous Steroid-Refractory Ulcerative Colitis ClinicalTrials.gov
    CXB722 DRUG Phase PHASE1 Stress ClinicalTrials.gov
    Fontolizumab DRUG Phase PHASE2 Arthritis, Rheumatoid ClinicalTrials.gov
    CX157 DRUG Phase PHASE1 Major Depressive Disorder ClinicalTrials.gov
    CXB909 DRUG Phase PHASE1 Healthy ClinicalTrials.gov
    apolizumab BIOLOGICAL Phase PHASE2 Lymphoma ClinicalTrials.gov
    NU172 DRUG Phase PHASE2 Heart Disease ClinicalTrials.gov
    visilizumab DRUG Phase PHASE2 Ulcerative Colitis ClinicalTrials.gov
    CX157 (TriRima) DRUG Phase PHASE2 Major Depressive Disorder ClinicalTrials.gov
    AX-024.HCl DRUG Phase PHASE1 Healthy Volunteers ClinicalTrials.gov
    FB825 DRUG Phase PHASE1 Healthy ClinicalTrials.gov
    REMUNE BIOLOGICAL Phase PHASE2 HIV/AIDS ClinicalTrials.gov
    Fentanyl DRUG Preclinical Quality of Life ClinicalTrials.gov
    Bortezomib DRUG Phase PHASE2 Graft-vs-Host Disease ClinicalTrials.gov
    Mycophenolate mofetil DRUG Phase PHASE2 Graft-vs-Host Disease ClinicalTrials.gov
    Sirolimus DRUG Phase PHASE2 Graft-vs-Host Disease ClinicalTrials.gov
    IR103 BIOLOGICAL Phase PHASE3 HIV ClinicalTrials.gov
    SOR-C13 DRUG Phase PHASE1 Cancer ClinicalTrials.gov
    Nowarta110 DRUG Phase PHASE1 Plantar Warts ClinicalTrials.gov
    ALS-008112 DRUG Phase PHASE1 Respiratory Syncytial Virus Infections ClinicalTrials.gov
    Placebo/Vehicle OTHER Phase PHASE1 Influenza ClinicalTrials.gov
    Lactose Placebo DRUG Phase PHASE2 Parainfluenza ClinicalTrials.gov
    AL-794 tablet DRUG Phase PHASE1 Influenza ClinicalTrials.gov
    AL-794 suspension DRUG Phase PHASE1 Influenza ClinicalTrials.gov
    Anagrelide CR DRUG Phase PHASE2 Thrombocytosis ClinicalTrials.gov
    Tenofovir disoproxil fumarate DRUG Phase PHASE1 Hepatitis B ClinicalTrials.gov
    Entecavir DRUG Phase PHASE1 Hepatitis B ClinicalTrials.gov
    AL-611 DRUG Phase PHASE1 Hepatitis C ClinicalTrials.gov
    Placebo Oral Tablet DRUG Phase PHASE2 Hepatitis B, Chronic ClinicalTrials.gov
    Peginterferon Alfa-2A DRUG Phase PHASE2 Hepatitis B, Chronic ClinicalTrials.gov
    AL-3778 DRUG Phase PHASE1 Hepatitis B ClinicalTrials.gov
    DAS181-F02 Nebulized Formulation Inhaled Dose DRUG Phase PHASE2 Parainfluenza ClinicalTrials.gov
    DAS181-F02 Dry Powder in Bulk DRUG Phase PHASE2 Parainfluenza ClinicalTrials.gov
    Leukine® (sargramostim, GM-CSF) and water for injection BIOLOGICAL Phase PHASE3 Breast Cancer With Low to Intermediate HER2 Expression ClinicalTrials.gov
    NeuVax™ vaccine BIOLOGICAL Phase PHASE3 Breast Cancer With Low to Intermediate HER2 Expression ClinicalTrials.gov
    AL-704 DRUG Phase PHASE1 Chronic Hepatitits C ClinicalTrials.gov
    Radiation RADIATION Phase PHASE1 Esophageal Cancer ClinicalTrials.gov
    SmartPill (TM) DEVICE Phase PHASE1 Healthy Volunteers ClinicalTrials.gov
    omeprazole/sodium bicarbonate DRUG Phase PHASE1 Healthy Volunteers ClinicalTrials.gov
    Nifedipine 60 MG Extended Release Oral Tablet DRUG Phase PHASE1 Healthy Volunteers ClinicalTrials.gov
    DAS181-F04 formulation DRUG Phase PHASE2 Influenza ClinicalTrials.gov
    DAS181-F02 formulation DRUG Phase PHASE2 Influenza ClinicalTrials.gov
    Lactose DRUG Phase PHASE1 Healthy ClinicalTrials.gov
    IFA Incomplete Freund's Adjuvant BIOLOGICAL Phase PHASE2 Multiple Sclerosis ClinicalTrials.gov
    Encochleated Amphotericin B DRUG Phase PHASE1 Cryptococcal Infections ClinicalTrials.gov
    Autologous Transplantation OTHER Phase PHASE2 Multiple Myeloma ClinicalTrials.gov
    High-Dose Melphalan HCL for Injection (Propylene Glycol-Free) DRUG Phase PHASE2 Multiple Myeloma ClinicalTrials.gov
    Bexarotene Capsules DRUG Phase PHASE1 Cutaneous T-cell Lymphoma ClinicalTrials.gov
    CiVi007 DRUG Phase PHASE1 Hypercholesterolemia ClinicalTrials.gov
    TBI 302 BIOLOGICAL Phase PHASE1 Hepatocellular Carcinoma ClinicalTrials.gov
    Respitose ML006 (DMV-Fonterra) DRUG Phase PHASE2 Influenza ClinicalTrials.gov
    DAS181 dry powder, formulation F02 DRUG Phase PHASE2 Influenza ClinicalTrials.gov
    Dexamethasone DRUG Phase PHASE1 Acute Lymphoblastic Leukemia ClinicalTrials.gov
    Vincristine Sulfate Liposomes Injection DRUG Phase PHASE1 Malignant Melanoma ClinicalTrials.gov
    Marqibo DRUG Phase PHASE1 Sarcoma ClinicalTrials.gov
    Simeprevir (SMV) DRUG Phase PHASE2 Chronic Hepatitis C ClinicalTrials.gov
    Odalasvir (ODV) DRUG Phase PHASE2 Chronic Hepatitis C ClinicalTrials.gov
    Pralatrexate DRUG Phase PHASE1 Cutaneous T-cell Lymphoma ClinicalTrials.gov
    IFA Placebo BIOLOGICAL Phase PHASE2 Secondary Progress Multiple Sclerosis ClinicalTrials.gov
    NeuroVax BIOLOGICAL Phase PHASE2 Multiple Sclerosis ClinicalTrials.gov
    Fluconazole DRUG Phase PHASE2 Vulvovaginitis ClinicalTrials.gov
    Oral Encochleated Amphotericin B (CAMB) DRUG Phase PHASE2 Acute Myeloid Leukemia ClinicalTrials.gov
    Vincristine Sulfate Liposome Injection plus rituximab DRUG Phase PHASE1 Non-Hodgkin's Lymphoma ClinicalTrials.gov
    Gemcitabine Hydrochloride DRUG Phase PHASE1 Relapsed or Refractory Lymphoproliferative Malignancies ClinicalTrials.gov
    10% IGIV BIOLOGICAL Phase PHASE3 Primary Immune Deficiency Diseases (PIDD) ClinicalTrials.gov
    Belinostat, Carboplatin, Paclitaxel DRUG Phase PHASE1 Stage IV Non-small Cell Lung Cancer ClinicalTrials.gov
    Docosahexaenoic Acid DRUG Phase PHASE2 Sickle Cell Disease ClinicalTrials.gov
    Vitamin B12 DRUG Phase PHASE2 Relapsed Peripheral T-Cell Lymphoma ClinicalTrials.gov
    Folic Acid DRUG Phase PHASE2 Relapsed Peripheral T-Cell Lymphoma ClinicalTrials.gov
    Folotyn and Leucovorin DRUG Phase PHASE2 Relapsed Peripheral T-Cell Lymphoma ClinicalTrials.gov
    FB704A DRUG Phase PHASE1 Rheumatoid Arthritis ClinicalTrials.gov
    Fusilev DRUG Phase PHASE1 Non Hodgkin's Lymphoma ClinicalTrials.gov
    Folotyn DRUG Phase PHASE1 Non Hodgkin's Lymphoma ClinicalTrials.gov
    JNJ-64417184 DRUG Phase PHASE1 Healthy ClinicalTrials.gov
    Vincristine Sulfate Liposome DRUG Phase PHASE1 Hematologic Diseases ClinicalTrials.gov
    SC411 DRUG Phase PHASE3 Sickle Cell Disease ClinicalTrials.gov
    AL-335 DRUG Phase PHASE2 Chronic Hepatitis C ClinicalTrials.gov
    AL-335 matching placebo DRUG Phase PHASE1 Chronic Hepatitis C ClinicalTrials.gov
    OBP-801 DRUG Phase PHASE1 Solid Tumor ClinicalTrials.gov
    Alkeran for Injection/Melphalan HCL for Injection (Propylene Glycol-Free) DRUG Phase PHASE2 Multiple Myeloma ClinicalTrials.gov
    Melphalan HCL for Injection (Propylene Glycol-Free)/Alkeran for Injection DRUG Phase PHASE2 Multiple Myeloma ClinicalTrials.gov
    Vamorolone 4% suspension for oral dosing DRUG Phase PHASE1 Pediatric Ulcerative Colitis ClinicalTrials.gov
    FB825, FB825-15D11, Anti-CemX DRUG Phase PHASE2 Atopic Dermatitis ClinicalTrials.gov
    Vamorolone 6.0 mg/day/day DRUG Phase PHASE2 Duchenne Muscular Dystrophy ClinicalTrials.gov
    Vamorolone 2.0 mg/day/day DRUG Phase PHASE2 Duchenne Muscular Dystrophy ClinicalTrials.gov
    Vamorolone 0.75 mg/day/day DRUG Phase PHASE2 Duchenne Muscular Dystrophy ClinicalTrials.gov
    Vamorolone 0.25 mg/day/day DRUG Phase PHASE2 Duchenne Muscular Dystrophy ClinicalTrials.gov
    Oncoquest-L vaccine BIOLOGICAL Phase PHASE2 Follicular Lymphoma ClinicalTrials.gov
    Oncoquest-CLL vaccine BIOLOGICAL Phase PHASE1 Chronic Lymphocytic Leukemia (CLL) ClinicalTrials.gov
    Belinostat IV DRUG Phase PHASE1 Solid Tumors ClinicalTrials.gov
    Placebo control OTHER Phase PHASE1 Pitt Hopkins Syndrome ClinicalTrials.gov
    AlloRx Stem Cells® BIOLOGICAL Phase PHASE1 Pitt Hopkins Syndrome ClinicalTrials.gov
    metoprolol succinate DRUG Phase PHASE2 Current or Recent History of Atrial Fibrillation ClinicalTrials.gov
    bucindolol hydrochloride DRUG Phase PHASE2 Current or Recent History of Atrial Fibrillation ClinicalTrials.gov
    STSA-1005 injection DRUG Phase PHASE1 Healthy ClinicalTrials.gov
    Cyclophosphamide DRUG Phase PHASE3 Breast Cancer ClinicalTrials.gov
    Epirubicin DRUG Phase PHASE3 Breast Cancer ClinicalTrials.gov
    Paclitaxel DRUG Phase PHASE3 Breast Cancer ClinicalTrials.gov
    Herceptin® BIOLOGICAL Phase PHASE3 Breast Cancer ClinicalTrials.gov
    GTB-3550 TriKE® Phase II DRUG Phase PHASE1 High-risk Myelodysplastic Syndromes ClinicalTrials.gov
    GTB-3550 TriKE® Phase I DRUG Phase PHASE1 High-risk Myelodysplastic Syndromes ClinicalTrials.gov
    Placebo for IV infusion DRUG Phase PHASE1 Bacterial Infections ClinicalTrials.gov
    QPX9003 for IV Infusion DRUG Phase PHASE1 Bacterial Infections ClinicalTrials.gov
    ZM-H1505R placebo OTHER Phase PHASE2 Hepatitis B, Chronic ClinicalTrials.gov
    ZM-H1505R DRUG Phase PHASE1 Healthy Volunteers ClinicalTrials.gov
    Placebo oral capsule DRUG Phase PHASE1 Bacterial Infections ClinicalTrials.gov
    QPX2015 DRUG Phase PHASE1 Bacterial Infections ClinicalTrials.gov
    Heparin DRUG Phase PHASE2 Covid19 ClinicalTrials.gov
    rNAPc2 DRUG Phase PHASE2 Coronary Disease ClinicalTrials.gov
    PPI-1011 DRUG Phase PHASE1 Rhizomelic Chondrodysplasia Punctata ClinicalTrials.gov
    Atazanavir DRUG Phase PHASE1 Solid Tumor ClinicalTrials.gov
    Belinostat DRUG Phase PHASE1 Peripheral T-cell Lymphoma ClinicalTrials.gov
    Meropenem DRUG Phase PHASE1 Bacterial Infections ClinicalTrials.gov
    Placebo:0.9% sodium chloride OTHER Phase PHASE1 Bacterial Infections ClinicalTrials.gov
    KSP-1007 DRUG Phase PHASE1 Bacterial Infections ClinicalTrials.gov
    CSB-111 DRUG Phase PHASE1 Healthy Volunteers ClinicalTrials.gov
    MAT2203 DRUG Phase PHASE3 Cryptococcal Meningitis ClinicalTrials.gov
    FP002 Injection DRUG Phase PHASE1 Advanced Solid Tumor ClinicalTrials.gov
    QPX2014 DRUG Phase PHASE1 Bacterial Infections ClinicalTrials.gov
    QPX7728 DRUG Phase PHASE1 Bacterial Infections ClinicalTrials.gov
    Herceptin (trastuzumab) BIOLOGICAL Phase PHASE3 HER2-positive Breast Cancer ClinicalTrials.gov
    TX05 (trastuzumab) BIOLOGICAL Phase PHASE3 Breast Cancer ClinicalTrials.gov
    placebo comparator DRUG Phase PHASE1 Bacterial Infections ClinicalTrials.gov
    QPX7831 DRUG Phase PHASE1 Bacterial Infections ClinicalTrials.gov
    Lamotrigine 100 MG DRUG Phase PHASE1 Fasting ClinicalTrials.gov
    Amphotericin B DRUG Phase PHASE3 Cryptococcal Meningitis ClinicalTrials.gov
    Sodium valproate DRUG Phase PHASE1 Food-drug Interaction ClinicalTrials.gov
    Testosterone Nasal Gel [Natesto] DRUG Phase PHASE1 Hypogonadism ClinicalTrials.gov
    AX-158 DRUG Phase PHASE1 Psoriasis ClinicalTrials.gov
    NBF-006 DRUG Phase PHASE1 Non-Small Cell Lung Cancer ClinicalTrials.gov
    Difamilast DRUG Phase PHASE3 Atopic Dermatitis ClinicalTrials.gov
    Tacrolimus DRUG Phase PHASE1 Healthy Volunteers ClinicalTrials.gov
    Telomelysin DRUG Phase PHASE2 Esophagogastric Adenocarcinoma ClinicalTrials.gov
    Valproic Acid 500 MG DRUG Phase PHASE1 Multiple Drug Use ClinicalTrials.gov
    Sodium valproate 500 MG DRUG Phase PHASE1 Multiple Drug Use ClinicalTrials.gov
    CB03-154 DRUG Phase PHASE2 Focal Epilepsy ClinicalTrials.gov
    UB_TT170 DRUG Phase PHASE1 Osteosarcoma ClinicalTrials.gov
    SCRI-E2CAR_EGFRtv1 BIOLOGICAL Phase PHASE1 Osteosarcoma ClinicalTrials.gov
    JNJ-440 DRUG Phase PHASE1 Chronic Hepatitis B ClinicalTrials.gov
    ABI-110 High Dose DRUG Phase PHASE1 Neovascular (Wet) AMD ClinicalTrials.gov
    ABI-110 Medium Dose DRUG Phase PHASE1 Neovascular (Wet) AMD ClinicalTrials.gov
    ABI-110 Low Dose DRUG Phase PHASE1 Neovascular (Wet) AMD ClinicalTrials.gov
    DAS181 OL DRUG Phase PHASE3 Lower Respiratory Tract Infection ClinicalTrials.gov
    DAS181 COVID-19 DRUG Phase PHASE3 Lower Respiratory Tract Infection ClinicalTrials.gov
    DAS181 DRUG Phase PHASE1 Influenza ClinicalTrials.gov
    Vehicle DRUG Phase PHASE1 Papulopustular Rosacea ClinicalTrials.gov
    Vamorolone DRUG Phase PHASE2 Becker Muscular Dystrophy ClinicalTrials.gov
    HCR-188 DRUG Phase EARLY_PHASE1 Obesity and Overweight ClinicalTrials.gov
    CB06-036 DRUG Phase PHASE1 Healthy Volunteers ClinicalTrials.gov
    Ceftibuten Placebo DRUG Phase PHASE1 Bacterial Infections ClinicalTrials.gov
    Sham Needle DRUG Phase PHASE3 Lumbar Degenerative Disc Disease ClinicalTrials.gov
    SB-01 For Injection DRUG Phase PHASE3 Lumbar Degenerative Disc Disease ClinicalTrials.gov
    AL-034 DRUG Phase PHASE1 Hepatitis B ClinicalTrials.gov
    CIVI 007 DRUG Phase PHASE2 Hypercholesterolemia ClinicalTrials.gov
    AIV007 DRUG Phase PHASE1 Neovascular Age-related Macular Degeneration ClinicalTrials.gov
    Ceftibuten DRUG Phase PHASE1 Bacterial Infections ClinicalTrials.gov
    Xeruborbactam Oral Prodrug DRUG Phase PHASE1 Bacterial Infections ClinicalTrials.gov
    AIV001 suspension DRUG Phase PHASE1 Superficial Basal Cell Carcinoma ClinicalTrials.gov
    AIV001 DRUG Phase PHASE1 Papulopustular Rosacea ClinicalTrials.gov
    Placebo DRUG Phase EARLY_PHASE1 Obesity and Overweight ClinicalTrials.gov
    Pembrolizumab DRUG Phase PHASE1 Advanced Solid Tumor ClinicalTrials.gov
    OBP-301 BIOLOGICAL Phase PHASE1 Esophageal Cancer ClinicalTrials.gov
    JNJ-63623872 DRUG Phase PHASE1 Influenza in Humans ClinicalTrials.gov
    Pitavastatin DRUG Phase PHASE1 Influenza in Humans ClinicalTrials.gov
    Midazolam DRUG Phase PHASE1 Influenza in Humans ClinicalTrials.gov
    Digoxin DRUG Phase PHASE1 Influenza in Humans ClinicalTrials.gov
    Oseltamivir DRUG Phase PHASE1 Influenza in Humans ClinicalTrials.gov
    AL-794 DRUG Phase PHASE1 Influenza ClinicalTrials.gov
    Iloprost Injection, for intravenous use DRUG Phase PHASE2 Raynaud Phenomenon Secondary to Systemic Sclerosis ClinicalTrials.gov
    Placebo IV infusion DRUG Phase PHASE2 Raynaud Phenomenon Secondary to Systemic Sclerosis ClinicalTrials.gov
    ALS-008176 DRUG Phase PHASE1 Respiratory Syncytial Virus Infections ClinicalTrials.gov
    Placebo group DRUG Phase PHASE2 Focal Epilepsy ClinicalTrials.gov
    Test drug CB03-154 20mg group DRUG Phase PHASE2 Focal Epilepsy ClinicalTrials.gov
    [14C]Xeruborbactam DRUG Phase PHASE1 ADME ClinicalTrials.gov
    [18F]CSB-321 DRUG Phase PHASE1 Metastatic Cancer ClinicalTrials.gov
    ZM-H1505R 100mg DRUG Phase PHASE3 Chronic Hepatitis B ClinicalTrials.gov
    Test drug CB03-154 15mg group DRUG Phase PHASE2 ALS (Amyotrophic Lateral Sclerosis) ClinicalTrials.gov
    Test drug CB03-154 10mg group DRUG Phase PHASE2 ALS (Amyotrophic Lateral Sclerosis) ClinicalTrials.gov
    Test drug CB03-154 5mg group DRUG Phase PHASE2 ALS (Amyotrophic Lateral Sclerosis) ClinicalTrials.gov
    Single Arm DRUG Phase PHASE1 Solid Tumor, Unspecified, Adult ClinicalTrials.gov
    Dextrose 5% in water DRUG Phase PHASE1 Bacterial Infections ClinicalTrials.gov
    Xeruborbactam/Cefiderocol DRUG Phase PHASE1 Bacterial Infections ClinicalTrials.gov
    Cefiderocol DRUG Phase PHASE1 Bacterial Infections ClinicalTrials.gov
    Xeruborbactam DRUG Phase PHASE1 Bacterial Infections ClinicalTrials.gov
    Cefiderocol/Xeruborbactam DRUG Phase PHASE1 Bacterial Infections ClinicalTrials.gov
    COP DRUG Phase PHASE3 Peripheral T Cell Lymphoma ClinicalTrials.gov
    CHOP DRUG Phase PHASE3 Peripheral T Cell Lymphoma ClinicalTrials.gov
    Pralatrexate Injection DRUG Phase PHASE1 Advanced Solid Tumors ClinicalTrials.gov
    Belinostat Injection DRUG Phase PHASE3 Peripheral T Cell Lymphoma ClinicalTrials.gov

    💼 Business Developments:

    • Partnership
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval: Not available
    • Executive Changes: Not available

    Structured Data:

    • Company Name: GT BIOPHARMA, INC.
    • Ticker Symbol: GTBP

Search

News categories